Health Briefs: Poland's Abortion Law Standoff, Novo Nordisk's Capitol Hill Scrutiny, and More

Current health news highlights include Poland's rejection of a bill to ease abortion laws, Novo Nordisk's Capitol Hill meeting over pulling Levemir, a study linking Ozempic with lower dementia risk, a court upholding Tennessee's birth certificate gender policy, and three presumptive human bird flu cases in Colorado.

Following is a summary of current health news briefs.

Poland's lower house has rejected a proposed bill to ease the country's stringent abortion laws, spotlighting fractures within the ruling coalition. The bill aimed to remove penalties for aiding abortions and for terminations due to fetal anomalies.

Novo Nordisk is facing scrutiny on Capitol Hill for its plan to discontinue Levemir insulin in the U.S. Senate aides will meet with the company's executives to discuss the implications of this decision, which has alarmed lawmakers.

A study from Oxford University suggests that Novo Nordisk's diabetes drug Ozempic may reduce the risk of cognitive problems. Researchers analyzed data from over 100 million U.S. medical records for their findings.

The U.S. Court of Appeals upheld Tennessee's policy against changing the gender listed on birth certificates, rejecting a constitutional challenge. This ruling affects transgender individuals born in the state.

Colorado reported three presumptive cases of H5 bird flu in poultry workers, according to the CDC. The workers contracted the virus amid an outbreak at a poultry facility and experienced mild symptoms.

(With inputs from agencies.)